Pfizer, Inc. ( PFE) - Payout Ratio History
Payout ratio history for stock PFE (Pfizer, Inc.).
| Date | Payout ratio |
|---|---|
| October 2024 | -365.22% |
| September 2024 | -365.22% |
| August 2024 | -3360% |
| July 2024 | -3360% |
| June 2024 | -3360% |
| May 2024 | 454.05% |
| April 2024 | 454.05% |
| March 2024 | 454.05% |
| February 2024 | 91.80% |
| January 2024 | 58.54% |
| December 2023 | 57.14% |
| November 2023 | 49.85% |
| October 2023 | 49.70% |
| September 2023 | 53.77% |
| August 2023 | 47.54% |
| July 2023 | 46.86% |
| June 2023 | 46.20% |
| May 2023 | 43.62% |
| April 2023 | 43.39% |
| March 2023 | 42.60% |
| February 2023 | 36.69% |
| January 2023 | 33.00% |
| December 2022 | 32.19% |
| November 2022 | 2.88% |
| October 2022 | 2.65% |
| September 2022 | 50.63% |
| August 2022 | 3.24% |
| July 2022 | 46.24% |
| June 2022 | 46.24% |
| May 2022 | 46.24% |
| April 2022 | 46.24% |
| March 2022 | 46.24% |
| February 2022 | 45.09% |
| January 2022 | 45.09% |
| December 2021 | 45.09% |
| October 2021 | 66.67% |
| September 2021 | 66.67% |
| August 2021 | 79.59% |
| July 2021 | 79.59% |
| June 2021 | 79.59% |
| May 2021 | 91.23% |
| April 2021 | 91.23% |
| March 2021 | 91.23% |
| February 2021 | 93.64% |
| January 2021 | 93.64% |
| December 2020 | 93.51% |
| November 2020 | 92.07% |
| October 2020 | 56.49% |
| September 2020 | 56.49% |
| August 2020 | 56.49% |
| July 2020 | 50.66% |
| June 2020 | 50.66% |
| May 2020 | 50.66% |
| April 2020 | 76.60% |
| March 2020 | 76.60% |
| February 2020 | 76.60% |
| January 2020 | 76.60% |
| December 2019 | 76.60% |
| November 2019 | 76.60% |
| October 2019 | 76.60% |
| September 2019 | 76.60% |
| August 2019 | 76.60% |
| July 2019 | 76.60% |
| June 2019 | 76.60% |
| May 2019 | 76.60% |
| April 2019 | 76.60% |
| March 2019 | 77.42% |
| February 2019 | 77.42% |
| December 2018 | 33.90% |
| December 2017 | 77.80% |
| December 2016 | 118% |
| December 2015 | 82.70% |
| December 2014 | 63% |
| December 2013 | 62.30% |
| December 2012 | 69.80% |
| December 2011 | 61.40% |
| December 2010 | 70.60% |
| December 2009 | 65% |
| December 2008 | 107.60% |
| December 2007 | 56.68% |
| December 2006 | 60.85% |
| December 2005 | 56.92% |
| December 2004 | 35.20% |
| December 2003 | 40.69% |
| December 2002 | 38.72% |
| December 2001 | 44.27% |
| December 2000 | 50.55% |
| December 1999 | 81.81% |
PFE
List: Contenders
Price: $30.19
Dividend Yield: 0.06%
Forward Dividend Yield: 5.56%
Payout Ratio: -365.22%
Dividend Per Share: 1.68 USD
Earnings Per Share: -0.46 USD
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - General
Volume: 23.8 million
Ebitda: 3.6 billionMarket Capitalization: 165.7 billion
Average Dividend Frequency: 4
Years Paying Dividends: 53
DGR3: 2.96%
DGR5: 5.72%
DGR10: 6.98%
DGR20: 7.05%